Argenx Se (ARGX) Times Interest Earned (2019 - 2026)
Argenx Se's (ARGX) quarterly Times Interest Earned came in at -$389.61 in Q2 2022, up 100.0% YoY from -$194.8 in Q2 2021, and down 266.71% on a QoQ basis from $233.71 in Q1 2022.
Analysis
Argenx Se (ARGX) Times Interest Earned (2019 - 2026) Analysis & Trends
Argenx Se (ARGX) has 3 years of Times Interest Earned data on file, last reported at -$389.61 in Q2 2022.
- Quarterly Times Interest Earned rose 100.0% year-over-year to -$389.61 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$879.17 (up 100.0% YoY) and the FY2025 annual result came in at $258.16, up 3037.58% from the prior year.
- Times Interest Earned retreated to -$389.61 in Q2 2022, from $233.71 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $233.71 in Q1 2022 to a low of -$11.0 billion in Q1 2021.
- A 3-year average of -$2.4 billion and a median of -$2751.0 in 2019 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 100.0% in 2022, down 100.0% in 2022.
- Tracing ARGX's Times Interest Earned over 3 years: stood at -$1348.9 in 2019, then plunged by 270953717.99% to -$3.7 billion in 2021, then soared by 100.0% to -$389.61 in 2022.
- The last three Times Interest Earned figures came in at -$389.61 (Q2 2022), $233.71 (Q1 2022), and -$3.7 billion (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 1.42 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 1,199.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -493.00 |
| Mar 31, 2026 | -394.00 |
| Dec 31, 2025 | -443.97 |
| Sep 30, 2025 | -348.63 |
| Jun 30, 2025 | -178.56 |
| Mar 31, 2025 | -139.00 |
| Dec 31, 2024 | -146.37 |
| Sep 30, 2024 | -20.99 |
| Jun 30, 2024 | 79.48 |
| Mar 31, 2024 | 182.46 |
| Dec 31, 2023 | 495.09 |
| Sep 30, 2023 | 348.87 |
| Jun 30, 2023 | 493.21 |
| Mar 31, 2023 | 551.82 |
| Dec 31, 2022 | 115.59 |
| Sep 30, 2022 | 265.78 |
| Jun 30, 2022 | -72.31 |
| Mar 31, 2022 | 233.71 |
| Dec 31, 2021 | 209.16 |
| Sep 30, 2021 | -6.46 |